BRCA1 p.Cys61=
c.183T>C · rs895070717 · VCV531482
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 6.2 | GERP 1, phastCons 1 |
| Overall | ||
| CADD | 12.11 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.00161% | 62,098 |
| European (non-Finnish)grpmax | 0.000256% | 390,831 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- BRCA1
- Protein
- p.Cys61=
- Coding
- c.183T>C
- MANE Select
- NM_007294
- dbSNP
- rs895070717
- Type
- single nucleotide variant
- Location
- chr17:43106485 (GRCh38)
- Gene constraint
- LOEUF 0.885 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 41.99 · 33 PDB
- Residue 61
- a UniProt-annotated variant site (in bc and oc; pathogenic; no interaction with bap1)
Disease context
hereditary breast ovarian cancer syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: breast-ovarian cancer, familial, susceptibility to, 1hereditary neoplastic syndrome
For Hereditary breast and/or ovarian cancer syndrome (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adult, Elderly
Similar variants
- BRCA1 p.Cys61Gly Pathogenic ★★★ same residue
- BRCA1 p.Cys61Arg Pathogenic/Likely pathogenic ★★ same residue
- BRCA1 p.Cys61Ser Pathogenic ★★ same residue
- BRCA1 p.Cys61Tyr Pathogenic ★★ same residue
- BRCA1 p.Cys61fs Pathogenic ★★★ same residue
- BRCA1 p.Cys61Phe Uncertain significance ★ ⚠ same residue
- BRCA1 c.134+3A>T Likely pathogenic ★★★ same condition
- BRCA1 c.135-1G>T Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/brca1-p-cys61 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown